Oxford Nanopore Technologies - ONTTF Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.83
▼ -0.07 (-3.68%)

This chart shows the closing price for ONTTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Oxford Nanopore Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONTTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONTTF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Oxford Nanopore Technologies in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.83.

This chart shows the closing price for ONTTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 investment analysts is to sell stock in Oxford Nanopore Technologies. This Sell consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
9/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
3/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
5/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
8/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
11/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
1/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
2/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/19/2023BarclaysLower TargetGBX 400 ➝ GBX 355
4/14/2023Royal Bank of CanadaLower TargetGBX 400 ➝ GBX 350
3/23/2023JPMorgan Chase & Co.Lower TargetGBX 460 ➝ GBX 390
3/17/2023Peel HuntInitiated CoverageReduce
2/13/2023Berenberg BankLower TargetGBX 671 ➝ GBX 529
2/7/2023BarclaysLower TargetGBX 420 ➝ GBX 400
1/3/2023JPMorgan Chase & Co.Lower TargetGBX 720 ➝ GBX 460
9/25/2022Piper SandlerLower TargetGBX 750 ➝ GBX 650
9/14/2022JPMorgan Chase & Co.Boost TargetGBX 710 ➝ GBX 720
8/23/2022BarclaysLower TargetGBX 500 ➝ GBX 420
5/31/2022BarclaysLower TargetGBX 700 ➝ GBX 500
4/29/2022Royal Bank of CanadaLower TargetGBX 700 ➝ GBX 400
3/29/2022JPMorgan Chase & Co.Lower TargetGBX 790 ➝ GBX 710
3/17/2022CitigroupUpgradeNeutral ➝ Buy
3/2/2022Piper SandlerInitiated CoverageOverweight
(Data available from 2/24/2019 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/27/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/24/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Oxford Nanopore Technologies logo
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Read More

Today's Range

Now: $1.83
Low: $1.81
High: $1.85

50 Day Range

MA: $2.17
Low: $1.75
High: $2.63

52 Week Range

Now: $1.83
Low: $1.75
High: $3.52

Volume

1,800 shs

Average Volume

17,417 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Oxford Nanopore Technologies?

The following Wall Street analysts have issued stock ratings on Oxford Nanopore Technologies in the last twelve months: Barclays PLC, JPMorgan Chase & Co., Peel Hunt, and Royal Bank of Canada.
View the latest analyst ratings for ONTTF.

What is the current price target for Oxford Nanopore Technologies?

0 Wall Street analysts have set twelve-month price targets for Oxford Nanopore Technologies in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Oxford Nanopore Technologies in the next year.
View the latest price targets for ONTTF.

What is the current consensus analyst rating for Oxford Nanopore Technologies?

Oxford Nanopore Technologies currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe ONTTF will underperform the market and that investors should sell shares of Oxford Nanopore Technologies.
View the latest ratings for ONTTF.

What other companies compete with Oxford Nanopore Technologies?

Other companies that are similar to Oxford Nanopore Technologies include 180 Life Sciences, 3SBio, 60 Degrees Pharmaceuticals, Abcam and Adocia. Learn More about companies similar to Oxford Nanopore Technologies.

How do I contact Oxford Nanopore Technologies' investor relations team?

Oxford Nanopore Technologies' physical mailing address is Gosling Building Edmund Halley Road Oxford Science Park Oxford OX4 4DQ United Kingdom. The company's listed phone number is 44 84 5034 7900. The official website for Oxford Nanopore Technologies is nanoporetech.com. Learn More about contacing Oxford Nanopore Technologies investor relations.